{"id":3667,"date":"2025-04-08T10:26:23","date_gmt":"2025-04-08T08:26:23","guid":{"rendered":"https:\/\/invivo.partners\/?post_type=portoflio_invivo&#038;p=3667"},"modified":"2026-07-06T10:07:55","modified_gmt":"2026-07-06T08:07:55","slug":"signadori-bio","status":"publish","type":"portoflio_invivo","link":"https:\/\/invivo.partners\/es\/portoflio_invivo\/signadori-bio\/","title":{"rendered":"Signadori Bio"},"content":{"rendered":"<p><strong data-start=\"54\" data-end=\"71\">Signadori Bio<\/strong> es una empresa biofarmac\u00e9utica en fase precl\u00ednica que est\u00e1 desarrollando una innovadora plataforma de terapia celular para transformar el tratamiento del c\u00e1ncer. La plataforma patentada de la compa\u00f1\u00eda se origin\u00f3 en el Institut Gustave Roussy, un centro oncol\u00f3gico de prestigio internacional.<\/p>\r\n<ul>\r\n<li>CEO: Selwyn Ho<\/li>\r\n<li>Fundadores cient\u00edficos: Dr. Jean-Luc Perfettini y la profesora Nathalie Chaput<\/li>\r\n<li>Ubicaci\u00f3n: Francia<\/li>\r\n<li>Web: <a href=\"https:\/\/www.signadoribio.com\/\" target=\"_blank\" rel=\"noopener\">signadoribio.com<\/a><\/li>\r\n<\/ul>\r\n","protected":false},"featured_media":0,"template":"","tipo_portfolio":[580],"class_list":["post-3667","portoflio_invivo","type-portoflio_invivo","status-publish","hentry","tipo_portfolio-invivoventuresiii"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Signadori Bio - Invivo Partners<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/invivo.partners\/es\/portoflio_invivo\/signadori-bio\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Signadori Bio - Invivo Partners\" \/>\n<meta property=\"og:description\" content=\"Signadori Bio es una empresa biofarmac\u00e9utica en fase precl\u00ednica que est\u00e1 desarrollando una innovadora plataforma de terapia celular para transformar el tratamiento del c\u00e1ncer. La plataforma patentada de la compa\u00f1\u00eda se origin\u00f3 en el Institut Gustave Roussy, un centro oncol\u00f3gico de prestigio internacional. CEO: Selwyn Ho Fundadores cient\u00edficos: Dr. Jean-Luc Perfettini y la profesora Nathalie\" \/>\n<meta property=\"og:url\" content=\"https:\/\/invivo.partners\/es\/portoflio_invivo\/signadori-bio\/\" \/>\n<meta property=\"og:site_name\" content=\"Invivo Partners\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-06T08:07:55+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/invivo.partners\/es\/portoflio_invivo\/signadori-bio\/\",\"url\":\"https:\/\/invivo.partners\/es\/portoflio_invivo\/signadori-bio\/\",\"name\":\"Signadori Bio - Invivo Partners\",\"isPartOf\":{\"@id\":\"https:\/\/invivo.partners\/#website\"},\"datePublished\":\"2025-04-08T08:26:23+00:00\",\"dateModified\":\"2026-07-06T08:07:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/invivo.partners\/es\/portoflio_invivo\/signadori-bio\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/invivo.partners\/es\/portoflio_invivo\/signadori-bio\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/invivo.partners\/es\/portoflio_invivo\/signadori-bio\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/invivo.partners\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Signadori Bio\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/invivo.partners\/#website\",\"url\":\"https:\/\/invivo.partners\/\",\"name\":\"Invivo Capital\",\"description\":\"Somos un fondo de capital riesgo especializado en proyectos early-stage del sector salud.\",\"publisher\":{\"@id\":\"https:\/\/invivo.partners\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/invivo.partners\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/invivo.partners\/#organization\",\"name\":\"Invivo Capital\",\"url\":\"https:\/\/invivo.partners\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg\",\"contentUrl\":\"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg\",\"width\":1200,\"height\":630,\"caption\":\"Invivo Capital\"},\"image\":{\"@id\":\"https:\/\/invivo.partners\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Signadori Bio - Invivo Partners","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/invivo.partners\/es\/portoflio_invivo\/signadori-bio\/","og_locale":"es_ES","og_type":"article","og_title":"Signadori Bio - Invivo Partners","og_description":"Signadori Bio es una empresa biofarmac\u00e9utica en fase precl\u00ednica que est\u00e1 desarrollando una innovadora plataforma de terapia celular para transformar el tratamiento del c\u00e1ncer. La plataforma patentada de la compa\u00f1\u00eda se origin\u00f3 en el Institut Gustave Roussy, un centro oncol\u00f3gico de prestigio internacional. CEO: Selwyn Ho Fundadores cient\u00edficos: Dr. Jean-Luc Perfettini y la profesora Nathalie","og_url":"https:\/\/invivo.partners\/es\/portoflio_invivo\/signadori-bio\/","og_site_name":"Invivo Partners","article_modified_time":"2026-07-06T08:07:55+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/invivo.partners\/es\/portoflio_invivo\/signadori-bio\/","url":"https:\/\/invivo.partners\/es\/portoflio_invivo\/signadori-bio\/","name":"Signadori Bio - Invivo Partners","isPartOf":{"@id":"https:\/\/invivo.partners\/#website"},"datePublished":"2025-04-08T08:26:23+00:00","dateModified":"2026-07-06T08:07:55+00:00","breadcrumb":{"@id":"https:\/\/invivo.partners\/es\/portoflio_invivo\/signadori-bio\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/invivo.partners\/es\/portoflio_invivo\/signadori-bio\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/invivo.partners\/es\/portoflio_invivo\/signadori-bio\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/invivo.partners\/es\/"},{"@type":"ListItem","position":2,"name":"Signadori Bio"}]},{"@type":"WebSite","@id":"https:\/\/invivo.partners\/#website","url":"https:\/\/invivo.partners\/","name":"Invivo Capital","description":"Somos un fondo de capital riesgo especializado en proyectos early-stage del sector salud.","publisher":{"@id":"https:\/\/invivo.partners\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/invivo.partners\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/invivo.partners\/#organization","name":"Invivo Capital","url":"https:\/\/invivo.partners\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/invivo.partners\/#\/schema\/logo\/image\/","url":"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg","contentUrl":"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg","width":1200,"height":630,"caption":"Invivo Capital"},"image":{"@id":"https:\/\/invivo.partners\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/portoflio_invivo\/3667","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/portoflio_invivo"}],"about":[{"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/types\/portoflio_invivo"}],"wp:attachment":[{"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/media?parent=3667"}],"wp:term":[{"taxonomy":"tipo_portfolio","embeddable":true,"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/tipo_portfolio?post=3667"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}